Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

3-(4-Fluoro-phen-yl)-2-(2-naphth-yloxy)-4-oxo-5-phenyl-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile.

ABSTRACT: The title compound, C(29)H(17)FN(4)O(2), may be used as a new precursor for obtaining bioactive mol-ecules. There are two crystallographically independent mol-ecules in the asymmetric unit. The phenyl ring, 4-fluoro-phenyl ring and 2-naphth-yloxy ring are twisted with respect to the pyrrolopyrimidine ring by 52.30 (11)/49.05 (11), 80.94 (10)/88.36 (10) and 60.58 (7)/83.76 (7)°, respectively. The crystal packing is stabilized by weak C-H⋯N hydrogen bonds.

SUBMITTER: Ma JK

PROVIDER: S-EPMC2970989 | biostudies-literature | 2009 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

3-(4-Fluoro-phen-yl)-2-(2-naphth-yloxy)-4-oxo-5-phenyl-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile.

Ma Jun-Kai JK He Mei M Hu Yang-Gen YG

Acta crystallographica. Section E, Structure reports online 20091003 Pt 11

The title compound, C(29)H(17)FN(4)O(2), may be used as a new precursor for obtaining bioactive mol-ecules. There are two crystallographically independent mol-ecules in the asymmetric unit. The phenyl ring, 4-fluoro-phenyl ring and 2-naphth-yloxy ring are twisted with respect to the pyrrolopyrimidine ring by 52.30 (11)/49.05 (11), 80.94 (10)/88.36 (10) and 60.58 (7)/83.76 (7)°, respectively. The crystal packing is stabilized by weak C-H⋯N hydrogen bonds. ...[more]

PMID: 21578245

Similar Datasets

3-(4-Fluoro-phen-yl)-2-(4-methoxy-phen-oxy)-4-oxo-5-phenyl-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile.

Project description:There are two crystallographically independent mol-ecules in the asymmetric unit of the title compound, C(26)H(17)FN(4)O(3), which differ in the dihedral angles between the aromatic rings (fluorophenyl, phenyl) and the pyrrolopyrimidine rings [0.6?(3)/76.3° and 73.7?(3)/64.6°, respectively]. The crystal structure is mainly stabilized by C-H?O and C-H?F inter-actions.

| S-EPMC2960589 | biostudies-literature

Ethyl 2-diethyl-amino-4-oxo-3,5-diphenyl-4,5-dihydro-3H-pyrrolo-[3,2-d]pyrimidine-7-carboxyl-ate.

Project description:In the title compound, C(25)H(26)N(4)O(3), the two fused pyrrolo-[3,2-d]pyrimidine rings form a dihedral angle of 3.7?(2)°. The two substituent phenyl rings are twisted with respect to the pyrrole and pyrimidine rings, making dihedral angles of 57.2?(2) and 69.0?(2)°, respectively. The ethyl and eth-oxy groups are disordered over two positions; the site occupancies are 0.53?(1) and 0.47?(1) for ethyl, and 0.63?(1) and 0.37?(1) for eth-oxy. The crystal packing features C-H?O hydrogen bonds.

| S-EPMC3254465 | biostudies-literature

Ethyl 3-(4-chloro-phen-yl)-2-(dipentyl-amino)-4-oxo-5-phenyl-4,5-dihydro-3H-pyrrolo-[3,2-d]pyrimidine-7-carboxyl-ate.

Project description:In the title compound, C(31)H(37)ClN(4)O(3), the fused rings of the pyrrolo-[3,2-d]pyrimidine system form a dihedral angle of 5.80?(11)°. The phenyl and benzene rings are twisted with respect to the mean plane of the pyrrolo-[3,2-d]pyrimidine system [maximum deviation = 0.077?(2)?Å], making dihedral angles of 61.05?(12) and 75.39?(10)°, respectively. The eth-oxy group is disordered over two positions with the site-occupancy ratio fixed at 0.54:0.46. In the crystal, mol-ecules are linked via C-H?O hydrogen bonds, forming a two-dimensional network lying parallel to the ab plane. There are also ?-? [centroid-centroid distances = 3.5954?(17) and 3.965?(2)?Å] and C-H?? inter-actions present.

| S-EPMC3393266 | biostudies-literature

2-Morpholino-4-oxo-4,5-dihydro-thio-phene-3-carbonitrile.

Project description:The title compound, C(9)H(10)N(2)O(2)S, was obtained from the treatment of ethyl 4-cyano-3-hydr-oxy-5-morpholinothio-phene-2-carboxyl-ate with concentrated HCl. The mean plane of the essentially planar dihydro-thio-phene ring is almost orthogonal to the mirror plane of the N-morpholine substituent, making a dihedral angle of 87.2 (2)°.

| S-EPMC2970977 | biostudies-literature

2-(2-Naphth-yloxy)pyrimidine.

Project description:In the title compound, C(14)H(10)N(2)O, the organic rings are inclined at an angle of 86.1 (1)°. The angle at the ether O atom is widened to 117.18 (14)°.

| S-EPMC2977450 | biostudies-literature

Ethyl 3-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[2,3-d]pyridazine-2-carboxyl-ate.

Project description:The title compound, C(10)H(11)N(3)O(3), was synthesized by the reaction of 3,5-bis-(ethoxy-carbon-yl)-2-formyl-4-methyl-1H-pyrrole and hydrazine hydrate. The angle between the pyrrole ring and the pyridazinone ring is 0.93?(9)°. In the crystal, inter-molecular N-H?O and N-H?N hydrogen-bond inter-actions link the mol-ecules into a two-dimensional network.

| S-EPMC2979812 | biostudies-other

2,3-Dihydro-1H-pyrrolo-[1,2-a]indole-9-carbonitrile.

Project description:The asymmetric unit of the title compound, C12H10N2, which may serve as a model for mitosenes, contains two independent mol-ecules. The conformation of the five-membered rings in both molecules is envelope, with the central CH2-CH2-CH2 C atom at the flap in each case. In the crystal, they inter-act by a combination of weak C-H⋯N and π-π inter-actions [centroid-centroid distances = 3.616 (1) and 3.499 (1) Å] and C-H⋯π contacts.

| S-EPMC3588846 | biostudies-literature

rac-Dimethyl 2-(tert-butyl-amino)-5-oxo-4,5-dihydro-pyrano[3,2-c]chromene-3,4-dicarboxyl-ate.

Project description:The title compound, C(20)H(21)NO(7), is asymmetric with a chiral centre located in the pyran ring and crystallizes as a racemate. The mol-ecular framework is somewhat bent; the coumarin moiety and the pyran ring are inclined by 7.85 (5)°. The mol-ecular structure is characterized by an intra-molecular N-H⋯O hydrogen bond, which generates an S(6) ring motif, and the crystal packing is stabilized by inter-molecular C-H⋯O hydrogen bonds. The 3-carboxyl-ate O atom is involved in both of them, having a bifurcated character.

| S-EPMC3247363 | biostudies-literature

3,8-Dimethyl-4-oxo-3,4-dihydro-quinazoline-6-carbonitrile.

Project description:In the title compound, C(11)H(9)N(3)O, the quinazoline unit is almost planar, with a mean deviation of 0.006 (1) Å from the least-squares plane defined by the ten constituent atoms. In the crystal, mol-ecules are linked by weak C-H⋯N hydrogen bonds.

| S-EPMC3379508 | biostudies-literature

5'-Amino-2-oxo-2',3'-dihydro-spiro-[indoline-3,7'-thieno[3,2-b]pyran]-6'-carbonitrile 1',1'-dioxide.

Project description:In the title compound, C(15)H(11)N(3)O(4)S, the dihedral angle between the mean planes of the dihydro-indol-2-one (r.m.s. deviation = 0.015?Å) and dihydro-thieno[3,2-b]pyran (r.m.s. deviation = 0.011?Å) ring systems is 89.53?(3)°. The crytal packing is consolidated by inter-molecular N-H?O and N-H?N hydrogen bonds, which link the mol-ecules into a two-dimensional network into sheets lying parallel to (100).

| S-EPMC3007879 | biostudies-other

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data